William Blair Investment Management, LLC Halozyme Therapeutics, Inc. Transaction History

William Blair Investment Management, LLC

$39 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$40.06 - $59.44 $29.2 Million - $43.4 Million	-730,081 Reduced 16.46%	3,706,003 $211 Million
Q3 2022 Nov 09, 2022	SELL	$38.53 - $51.78 $5.04 Million - $6.77 Million	-130,787 Reduced 2.86%	4,436,084 $175 Million
Q2 2022 Aug 10, 2022	SELL	$37.35 - $48.3 $28.9 Million - $37.3 Million	-773,020 Reduced 14.48%	4,566,871 $201 Million
Q1 2022 May 11, 2022	BUY	$31.97 - $41.06 $8.51 Million - $10.9 Million	266,226 Added 5.25%	5,339,891 $213 Million
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $2.45 Million - $3.14 Million	76,957 Added 1.54%	5,073,665 $204 Million
Q3 2021 Nov 10, 2021	BUY	$38.47 - $46.42 $4.39 Million - $5.3 Million	114,222 Added 2.34%	4,996,708 $203 Million
Q2 2021 Aug 12, 2021	SELL	$38.84 - $51.31 $17.7 Million - $23.3 Million	-454,976 Reduced 8.52%	4,882,486 $222 Million
Q1 2021 May 13, 2021	SELL	$39.51 - $51.45 $40.5 Million - $52.7 Million	-1,024,882 Reduced 16.11%	5,337,462 $223 Million
Q4 2020 Feb 09, 2021	SELL	$25.81 - $43.62 $4.08 Million - $6.9 Million	-158,182 Reduced 2.43%	6,362,344 $272 Million
Q3 2020 Nov 06, 2020	SELL	$25.74 - $29.63 $1.5 Million - $1.72 Million	-58,086 Reduced 0.88%	6,520,526 $171 Million
Q2 2020 Aug 12, 2020	BUY	$16.25 - $26.81 $243,847 - $402,310	15,006 Added 0.23%	6,578,612 $176 Million
Q1 2020 May 08, 2020	BUY	$13.9 - $21.83 $3.23 Million - $5.07 Million	232,076 Added 3.67%	6,563,606 $118 Million
Q4 2019 Feb 12, 2020	BUY	$14.93 - $19.53 $13.7 Million - $17.9 Million	915,535 Added 16.9%	6,331,530 $112 Million
Q3 2019 Nov 12, 2019	BUY	$15.2 - $17.69 $28.5 Million - $33.2 Million	1,877,068 Added 53.04%	5,415,995 $84 Million
Q2 2019 Aug 09, 2019	BUY	$14.75 - $17.26 $46.2 Million - $54.1 Million	3,134,003 Added 773.97%	3,538,927 $60.8 Million
Q1 2019 May 10, 2019	BUY	$13.94 - $17.58 $5.64 Million - $7.12 Million	404,924 New	404,924 $6.52 Million

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$838 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$613 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$315 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$193 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$162 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of William Blair Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on William Blair Investment Management, LLC with notifications on news.

Account